Jubilant Biosys Jubilant Biosys Limited (JBL) is a company that provides biotechnology and pharmaceutical services. | Concept Life Sciences Concept Life Sciences is a knowledge-based, science-led contract research organization providing services to clients in the pharmaceutical, biotechnology, food, agrochemical, petrochemical, chemical, cosmetics, and consumer products sectors. | Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 1998 | Founding Date 2008 | Founding Date 2014 | Founding Date 1976 | Founding Date 1985 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Noida, IN HQ Bengaluru, IN Greater Noida, IN Karnataka, IN Noida, IN Yardley, US | Locations Cranbury, US HQ Parkville, AU Montréal, CA Shanghai, CN Paris, FR Berlin, DE Secunderabad, IN see more | Locations Alderley Edge, GB HQ Bar Hill, GB Bradford, GB Derbyshire, GB Dundee, GB Sandwich, GB | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Vacaville, US | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 1,7611% increase | Employees 1,33816% increase | Employees 73 | Employees 17,870 | Employees 8,933 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) ₹5.4b (FY, 2023) | Revenue (est.) $354.3m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥12.2b (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $141m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥4.5b (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit $213.3m (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit ¥7.8b (FY, 2023) |
Net income | Net income N/A | Net income ($55.4m) (FY, 2023) | Net income (£1.4m) (FY, 2019) | Net income N/A | Net income ¥1.9b (FY, 2023) |